E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/1/2009 in the Prospect News Bank Loan Daily and Prospect News Distressed Debt Daily.

Chem Rx gets forbearance agreement through June 15 for two loans

By Sara Rosenberg

New York, May 1 - Chem Rx Corp. signed a 45-day forbearance agreement with lenders under its two credit facilities that is in effect through June 15, according to a news release.

During the forbearance period, the company plans on continuing negotiations for waivers or amendments to the facilities.

As previously announced, the company was in technical violation of three financial covenants under its credit facilities and has not paid its default interest - but all required principal and non-default interest payments have been made.

Covenants that were breached include ratios of EBITDA to fixed charges and total debt, and capital expenditures restrictions.

Chem Rx is a Long Beach, N.Y.-based provider of institutional pharmacy services.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.